glp-1 obesity drug news today As drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: “Ozempic feet.” Story🔗below GLP-1 medications could cut US
Description
Lakhani M, Kwan ATH, Mihalache A, et al
For example, poor blood sugar balance can increase cravings and energy crashes
The second part of the guideline is more useful, suggesting that patients could undergo 24-hour liquid fasts or rapid sequence induction to minimize risks of aspiration
J.et al (2022)
55 A systematic review and meta-analysis of 7 RCTs was done to see the efficacy and safety of orforglipron and danuglipron in the treatment of T2DM and obesity
